INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "TREATMENT OF NEUROIMMUNE DISEASES USING A POPULATION OF CD19 CAR-EXPRESSING CELLS"

GENEVA, April 6 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/IB2025/059674) for "TREATMENT OF NEUROIMMUNE DISEASES USING A POPULATION OF CD19 CAR-EXPRESSING CELLS" on Sep 25, 2025. With publication no. WO/2026/069200, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ADIWIJAYA, Bambang (Novartis institutes for BioMedical Research, Inc.250 Massachusetts AvenueCambridge, Massachusetts 02139), AWASTHI, Rakesh (Novartis Pharmaceuticals Corporation59 Route 10East Hanover, New Jersey 07936), PEARSON,...